Cargando…
Analysing non-synonymous mutations in XDR and MDR tuberculosis drugs
Tuberculosis is a bacterial disease caused by Mycobacterium tuberculosis. It is known to be the second-largest cause of death and models a severe risk to public health throughout the world. Though it affects people of almost every age, individuals with weakened immune systems, (e.g., HIV infection)...
Autores principales: | Surana, Pallavi, Jainarayanan, Ashwin Kumar, Anand, Nithishwer Mouroug, Sharma, Mukta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880092/ https://www.ncbi.nlm.nih.gov/pubmed/31788566 http://dx.doi.org/10.1016/j.jctube.2019.100124 |
Ejemplares similares
-
MDR & XDR Tuberculosis
por: Kumar, Prahlad
Publicado: (2017) -
A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing
por: Anand, Nithishwer Mouroug, et al.
Publicado: (2021) -
Transmission of MDR and XDR Tuberculosis in Shanghai, China
por: Zhao, Ming, et al.
Publicado: (2009) -
Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
por: Codecasa, Luigi R., et al.
Publicado: (2017) -
Activity of Semi-Synthetic Mulinanes against MDR, Pre-XDR, and XDR Strains of Mycobacterium tuberculosis
por: Martínez-González, María Alejandrina, et al.
Publicado: (2021)